Table 1.
Baseline characteristics by assigned treatment and randomization strata for BARI 2D patients with follow-up health status data
| Insulin Sensitization (n=1080) | Insulin Provision (n=1083) | Revascularization (n=1059) | Medical Therapy (n=1104) | CABG-Intended |
PCI-Intended |
|||
|---|---|---|---|---|---|---|---|---|
| Revascularization (n=342) | Medical Therapy (n=359) | Revascularization (n=717) | Medical Therapy (n=745) | |||||
| Age (years) | 62.3 | 62.3 | 62.2 | 62.4 | 62.7 | 63.3 | 61.9 | 61.9 |
| Male (%) | 70.4 | 70.9 | 70.7 | 70.6 | 74.6 | 78.3 | 68.9 | 66.8 |
| Current Smoking (%) | 12.6 | 11.8 | 12.9 | 11.5 | 11.7 | 9.8 | 13.4 | 12.4 |
| Body Mass Index (kg/m2) | 31.8 | 31.7 | 31.6 | 31.9 | 30.0 | 30.8 | 32.4 | 32.5 |
| Prior Myocardial Infarction (%) | 32.4 | 30.9 | 30.5 | 32.7 | 33.5 | 39.6 | 29.0 | 29.4 |
| History of Heart Failure (%) | 5.7 | 6.7 | 6.6 | 5.8 | 4.7 | 3.4 | 7.6 | 6.9 |
| Angina (%) | ||||||||
| None | 38.5 | 40.9 | 37.8 | 41.5 | 33.6 | 42.9 | 39.8 | 40.8 |
| Stable CCS I/II | 43.4 | 42.6 | 41.8 | 44.2 | 42.1 | 47.6 | 41.6 | 42.6 |
| Stable CCS III/IV or Unstable | 18.1 | 16.5 | 20.4 | 14.3 | 24.3 | 9.5 | 18.6 | 16.6 |
| Duration of Diabetes (years) | 10.0 | 10.6 | 10.1 | 10.6 | 10.0 | 10.8 | 10.1 | 10.4 |
| Insulin Use (%) | 26.7 | 28.4 | 26.7 | 28.4 | 20.5 | 24.0 | 29.7 | 30.5 |
| DASI (score, 0–58.2) | 18.9 | 19.3 | 19.1 | 19.1 | 17.4 | 19.4 | 19.9 | 18.9 |
| Energy (score, 0–100) | 52.1 | 51.6 | 51.2 | 52.5 | 56.4 | 59.2 | 48.8 | 49.3 |
| Health Distress (score, 0–100) | 40.1 | 40.6 | 40.7 | 40.0 | 38.5 | 33.9 | 41.8 | 42.9 |
| Self-rated Health (score, 0–100) | 39.2 | 38.5 | 39.5 | 38.3 | 39.6 | 39.6 | 39.4 | 37.6 |